日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study

ALXN1820（Tarperprumig）在健康成人中的安全性、耐受性、药代动力学、药效学和免疫原性：一项I期研究的结果

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70190
Sandhu, Avner; Shen, Tong; Herrero, Paz Martin; Yuan, Chao-Xing; Qureshi, Samirah; Jiang, Xiaoyu; Sheng, Ye; Gasteyger, Christoph; Dai, Yang
免疫/内分泌
发表日期：2025
文献求助 收藏

PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare database

PLASMIC评分辅助诊断aHUS：C5抑制剂临床试验和PINC AI™医疗保健数据库分析

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-025-04156-6
Uriol-Rivera, Miguel G; Ernst, Frank R; Booth, John N 3rd; Comas, Àngels; Gasteyger, Christoph; Tomazos, Ioannis; Lum, Ching; Wang, Yan; Ávila, Ana I
发表日期：2025
文献求助 收藏

Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome

治疗偏好和生活质量影响：拉武利珠单抗与依库珠单抗治疗非典型溶血性尿毒综合征

期刊:Journal of Comparative Effectiveness Research
影响因子:2.5
doi:10.57264/cer-2023-0036
Mauch, Teri J; Chladek, Michael R; Cataland, Spero; Chaturvedi, Shruti; Dixon, Bradley P; Garlo, Katherine; Gasteyger, Christoph; Java, Anuja; Leguizamo, Jorge; Lloyd-Price, Lucy; Pham, Tan P; Symonds, Tara; Tomazos, Ioannis; Wang, Yan
发表日期：2023
文献求助 收藏

Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome

非典型溶血性尿毒综合征早期院内诊断和启动依库珠单抗治疗的经济影响

期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-019-00862-w
Ryan, Michael; Donato, Bonnie M K; Irish, William; Gasteyger, Christoph; L'Italien, Gilbert; Laurence, Jeffrey
发表日期：2020
文献求助 收藏

Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis

依库珠单抗治疗阵发性睡眠性血红蛋白尿和非典型溶血性尿毒综合征：10 年药物警戒分析

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.15790
Socié, Gérard; Caby-Tosi, Marie-Pierre; Marantz, Jing L; Cole, Alexander; Bedrosian, Camille L; Gasteyger, Christoph; Mujeebuddin, Arshad; Hillmen, Peter; Vande Walle, Johan; Haller, Hermann
发表日期：2019
文献求助 收藏

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome

目前关于非典型溶血性尿毒综合征患者停用依库珠单抗的证据

期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfw115
Macia, Manuel; de Alvaro Moreno, Fernando; Dutt, Tina; Fehrman, Ingela; Hadaya, Karine; Gasteyger, Christoph; Heyne, Nils
发表日期：2017
文献求助 收藏

Differential diagnosis of thrombotic microangiopathy in nephrology

肾脏病学中血栓性微血管病的鉴别诊断

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-017-0727-y
Sakari Jokiranta, T; Viklicky, Ondrej; Al Shorafa, Saleh; Coppo, Rosanna; Gasteyger, Christoph; Macia, Manuel; Pankratenko, Tatiana; Shenoy, Mohan; Soylemezoglu, Oğuz; Tsimaratos, Michel; Wetzels, Jack; Haller, Hermann
心血管
发表日期：2017
文献求助 收藏

An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry

全球非典型溶血性尿毒综合征注册中心：罕见病患者与行业支持的注册机构之间创新且协作的伙伴关系

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-016-0537-5
Woodward, Len; Johnson, Sally; Walle, Johan Vande; Beck, Joran; Gasteyger, Christoph; Licht, Christoph; Ariceta, Gema
发表日期：2016
文献求助 收藏

The global aHUS registry: methodology and initial patient characteristics

全球非典型溶血性尿毒综合征（aHUS）登记研究：方法学和初始患者特征

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-015-0195-1
Licht, Christoph; Ardissino, Gianluigi; Ariceta, Gema; Cohen, David; Cole, J Alexander; Gasteyger, Christoph; Greenbaum, Larry A; Johnson, Sally; Ogawa, Masayo; Schaefer, Franz; Vande Walle, Johan; Frémeaux-Bacchi, Véronique
发表日期：2015
文献求助 收藏